In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Napton Drug Master File in Korea (Napton KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Napton. The MFDS reviews the Napton KDMF as part of the drug registration process and uses the information provided in the Napton KDMF to evaluate the safety and efficacy of the drug.
After submitting a Napton KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Napton API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Napton suppliers with KDMF on PharmaCompass.